S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843532.08926.df |
| _version_ | 1827336932095426560 |
|---|---|
| author | G. Montalban-Bravo F. Ma I. Ganan-Gomez R. Kanagal-Shamana V. Adema N. Thongon H. Yang K. A. Soltysiak C. Bueso-Ramos H. Kantarjian G. Garcia-Manero S. Colla |
| author_facet | G. Montalban-Bravo F. Ma I. Ganan-Gomez R. Kanagal-Shamana V. Adema N. Thongon H. Yang K. A. Soltysiak C. Bueso-Ramos H. Kantarjian G. Garcia-Manero S. Colla |
| author_sort | G. Montalban-Bravo |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:30Z |
| format | Article |
| id | doaj.art-5e458288cf8e46059b68df79cc956369 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:30Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-5e458288cf8e46059b68df79cc9563692024-03-02T03:51:39ZengWileyHemaSphere2572-92412022-06-016616210.1097/01.HS9.0000843532.08926.df202206003-00061S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVELG. Montalban-Bravo0F. Ma1I. Ganan-Gomez2R. Kanagal-Shamana3V. Adema4N. Thongon5H. Yang6K. A. Soltysiak7C. Bueso-Ramos8H. Kantarjian9G. Garcia-Manero10S. Colla111 Leukemia, The University of Texas MD Anderson Cancer Center, Houston2 Molecular Biology Institute, University of California, Los Angeles1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston3 Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, United States of America1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston3 Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, United States of America1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston1 Leukemia, The University of Texas MD Anderson Cancer Center, Houston1 Leukemia, The University of Texas MD Anderson Cancer Center, Houstonhttp://journals.lww.com/10.1097/01.HS9.0000843532.08926.df |
| spellingShingle | G. Montalban-Bravo F. Ma I. Ganan-Gomez R. Kanagal-Shamana V. Adema N. Thongon H. Yang K. A. Soltysiak C. Bueso-Ramos H. Kantarjian G. Garcia-Manero S. Colla S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL HemaSphere |
| title | S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL |
| title_full | S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL |
| title_fullStr | S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL |
| title_full_unstemmed | S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL |
| title_short | S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE-CELL LEVEL |
| title_sort | s160 molecular determinants of disease progression after hypomethylating agent therapy in ras pathway mutant chronic myelomonocytic leukemia at the single cell level |
| url | http://journals.lww.com/10.1097/01.HS9.0000843532.08926.df |
| work_keys_str_mv | AT gmontalbanbravo s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT fma s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT iganangomez s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT rkanagalshamana s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT vadema s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT nthongon s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT hyang s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT kasoltysiak s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT cbuesoramos s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT hkantarjian s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT ggarciamanero s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel AT scolla s160moleculardeterminantsofdiseaseprogressionafterhypomethylatingagenttherapyinraspathwaymutantchronicmyelomonocyticleukemiaatthesinglecelllevel |